Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › nitazoxanide

nitazoxanide

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of nitazoxanide

13 trials tracked of nitazoxanide: 8 in phase 3 or 4 and 1 with published results. The most-cited published study has 44 citations.

13Trials tracked
8Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 7 Phase 2 5
  1. Phase 3 Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19 Completed · 44 cited
  2. Phase 4 The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients Completed
  3. Phase 3 Compassionate Use of Nitazoxanide for the Treatment of Clostridium Difficile Infection Completed
  4. Phase 3 Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection Completed
  5. Phase 3 A Phase III, Randomized, Double-Blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Nitazoxanide in the Treatment of Uncomplicated Influenza Completed
  6. Phase 3 Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection Completed
Show 7 more trials
  1. Phase 3 Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated Influenza Completed
  2. Phase 3 Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV) Completed
  3. Phase 2 Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients Completed
  4. Phase 2 Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C Completed
  5. Phase 2 NNITS-Nitazoxanide for Norovirus in Transplant Patients Study Completed
  6. Phase 2 Nitazoxanide Versus Placebo for the Treatment of Hospitalized Subjects With Severe Acute Respiratory Illness Completed
  7. Phase 2 Study of Nitazoxanide Compared to Placebo in Subjects With HBeAG-Negative Chronic Hepatitis B Completed

Showing the 13 most-cited and recently-updated of 13 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Meta-analysis: Nitazoxanide triple therapy improves H. pylori eradication vs standard triple therapy
Infectious Disease Meta-analysis
Meta-analysis: Nitazoxanide triple therapy improves H. pylori eradication vs standard triple therapy Nitazoxanide triple therapy significantly improves H. pylori cure rates compared to standard treatment
This systematic review and meta-analysis of 1286 participants found that nitazoxanide-based triple therapy significantly improved H.
A large review of 1286 patients found that adding nitazoxanide to standard triple therapy significantly improved H. pylori cure rates and re…
May 1, 2026